Insensitivity to RAF inhibition in BRAFV600E melanomas frequently arises from adaptive responses that reactivate ERK (Lito et al, 2012) or up-regulate other pro-growth pathways such as the PI3K/AKT cascade (Shi et al, 2014a; Sun et al, 2014). The gene discussed is AKT1; the disease is melanoma.